Ohemo, Teva Drop Patent Suit on Copycat of MorphaBond Painkiller

Inspirion Delivery Sciences, a closely held company that sold its assets to the private Ohemo Life Sciences this year, had claimed that Teva’s proposed generic version of an abuse-deterrent form of the painkiller morphine infringes patents for MorphaBond.

• No details were provided in order of dismissal, filed Monday in federal court in Newark, New Jersey
• Patent expires in August 2028, according to complaint
• NOTE: Ohemo on April 30 bought the assets of Inspirion, including the two patents at issue in this case; Inspirion filed the original complaint
• CASE: Ohemo Life Sciences Inc. v. Teva Pharmaceuticals USA Inc., 19-cv-10464 ...